CD274 and cancer: In this tumor model, the combination of inhibiting the PD-L1/PD-1 pathway, restoring T cell recognition, and repolarizing M1 macrophages via multifunctional EVs may produce satisfactory antitumor activity, thus suggesting its potential as a novel method of cancer treatment.